AQST Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.85%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $429,750.00

Aquestive Therapeutics Insider Trading History Chart

Aquestive Therapeutics Share Price & Price History

^$4.56

▲ +0.05 (1.11%)

As of 11/22/2024 01:00 AM ET

Days: 30 | 90 | 365

9 hidden AI stocks set to thrive in Trump’s new era

From StockEarnings | Ad

AI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be worth trillions of dollars (here’s how to tap into this new wealth)

Get the Name of These AI Picks Now

Aquestive Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/15/2024	Alexander Mark Schobel	Insider	Sell	50,000	$6.00	$300,000.00	984,476
3/8/2024	Alexander Mark Schobel	Insider	Sell	25,000	$5.19	$129,750.00	1,040,371
6/14/2022	Peter E Boyd	SVP	Buy	5,000	$0.81	$4,050.00	59,532
6/8/2022	Alexander Mark Schobel	Insider	Buy	45,871	$0.96	$44,036.16	882,871
6/8/2022	Daniel Barber	CEO	Buy	91,743	$0.96	$88,073.28	193,702
6/8/2022	Lori J Braender	General Counsel	Buy	13,761	$0.96	$13,210.56	38,761
6/8/2022	Peter E Boyd	SVP	Buy	2,293	$0.96	$2,201.28	54,532

9 hidden AI stocks set to thrive in Trump’s new era

From StockEarnings | Ad

AI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be worth trillions of dollars (here’s how to tap into this new wealth)

Get the Name of These AI Picks Now

SEC Filings (Institutional Ownership Changes) for Aquestive Therapeutics (NASDAQ:AQST)

32.45% of Aquestive Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Aquestive Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/20/2024	Virtu Financial LLC	22,986	$0.11M	0.0%	-39.4%	0.025%
11/19/2024	Barclays PLC	99,312	$0.50M	0.0%	+285.4%	0.109%
11/16/2024	Geode Capital Management LLC	1,667,515	$8.31M	0.0%	+5.7%	1.829%
11/15/2024	Barclays PLC	99,312	$0.50M	0.0%	+285.4%	0.109%
11/15/2024	Wellington Management Group LLP	185,191	$0.92M	0.0%	N/A	0.203%
11/15/2024	State Street Corp	1,496,739	$7.45M	0.0%	+52.1%	1.642%
11/15/2024	Stifel Financial Corp	95,944	$0.48M	0.0%	-75.9%	0.105%
11/14/2024	Verition Fund Management LLC	199,729	$1M	0.0%	N/A	0.219%
11/14/2024	MetLife Investment Management LLC	36,096	$0.18M	0.0%	+86.3%	0.040%
11/13/2024	BNP Paribas Financial Markets	18,826	$94K	0.0%	+252.2%	0.021%
11/13/2024	Quantbot Technologies LP	27,198	$0.14M	0.0%	N/A	0.030%
11/12/2024	Charles Schwab Investment Management Inc.	203,540	$1.01M	0.0%	+4.8%	0.223%
11/9/2024	Intech Investment Management LLC	18,032	$90K	0.0%	N/A	0.020%
11/5/2024	GSA Capital Partners LLP	137,151	$0.68M	0.1%	+525.5%	0.151%
11/4/2024	Chartwell Investment Partners LLC	107,550	$0.54M	0.0%	N/A	0.118%
11/1/2024	Cahill Wealth Management LLC	142,941	$0.71M	0.4%	+20.6%	0.157%
10/29/2024	Harvey Capital Management Inc.	17,600	$88K	0.0%	N/A	0.019%
10/29/2024	Janney Montgomery Scott LLC	923,285	$4.60M	0.0%	+4.9%	1.014%
10/25/2024	Financial Advocates Investment Management	39,000	$0.19M	0.0%	+14.7%	0.043%
10/24/2024	PFG Investments LLC	48,200	$0.24M	0.0%	-18.3%	0.053%
10/22/2024	International Assets Investment Management LLC	19,920	$0.99M	0.0%	N/A	0.022%
10/16/2024	nVerses Capital LLC	5,700	$28K	0.0%	N/A	0.006%
10/11/2024	Creative Planning	92,822	$0.46M	0.0%	+39.3%	0.102%
10/3/2024	SG Americas Securities LLC	25,619	$0.13M	0.0%	+58.9%	0.028%
9/5/2024	Sanctuary Advisors LLC	63,270	$0.17M	0.0%	N/A	0.069%
8/15/2024	Blue Owl Capital Holdings LP	1,140,000	$2.96M	0.8%	+30.3%	1.252%
8/15/2024	The Manufacturers Life Insurance Company	29,371	$76K	0.0%	N/A	0.032%
8/15/2024	Deerfield Management Company L.P. Series C	146,155	$0.38M	0.0%	N/A	0.161%
8/14/2024	Marshall Wace LLP	77,016	$0.20M	0.0%	N/A	0.085%
8/12/2024	Marathon Trading Investment Management LLC	18,225	$47K	0.0%	-79.8%	0.020%
8/9/2024	Renaissance Technologies LLC	496,200	$1.29M	0.0%	-63.9%	0.545%
8/7/2024	PFG Investments LLC	59,000	$0.15M	0.0%	+22.9%	0.065%
8/5/2024	Victory Capital Management Inc.	10,299	$27K	0.0%	N/A	0.011%
8/1/2024	Rhumbline Advisers	97,837	$0.25M	0.0%	N/A	0.107%
7/29/2024	Financial Advocates Investment Management	34,000	$88K	0.0%	+70.0%	0.037%
7/26/2024	Legato Capital Management LLC	242,371	$0.63M	0.1%	-2.5%	0.266%
7/26/2024	Bank of New York Mellon Corp	228,351	$0.59M	0.0%	N/A	0.251%
5/20/2024	Virtu Financial LLC	102,836	$0.44M	0.0%	+219.7%	0.113%
5/15/2024	Lazard Asset Management LLC	29,112	$0.12M	0.0%	+115.5%	0.032%
5/10/2024	Acadian Asset Management LLC	533,567	$2.27M	0.0%	-3.1%	0.586%
5/10/2024	Vanguard Group Inc.	3,242,571	$13.81M	0.0%	+71.7%	3.562%
5/7/2024	SG Americas Securities LLC	12,625	$54K	0.0%	N/A	0.014%
5/3/2024	Essex Investment Management Co. LLC	612,949	$2.61M	0.5%	-27.6%	0.673%
5/1/2024	Janney Montgomery Scott LLC	341,860	$1.46M	0.0%	N/A	0.376%
4/22/2024	PFG Investments LLC	48,000	$0.20M	0.0%	N/A	0.065%
2/13/2024	Armistice Capital LLC	3,924,000	$7.93M	0.1%	-18.3%	5.877%
2/8/2024	Essex Investment Management Co. LLC	846,167	$1.71M	0.3%	N/A	1.267%
2/7/2024	Jump Financial LLC	29,812	$60K	0.0%	N/A	0.045%
1/25/2024	Vahanian & Associates Financial Planning Inc.	591,608	$1.20M	4.7%	-18.1%	0.886%
1/16/2024	Legato Capital Management LLC	340,564	$0.69M	0.1%	N/A	0.510%
11/15/2023	Armistice Capital LLC	4,800,000	$7.34M	0.1%	+314.5%	7.189%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	247,828	$0.38M	0.0%	+14.2%	0.371%
11/13/2023	Acadian Asset Management LLC	550,484	$0.84M	0.0%	+238.8%	0.824%
8/8/2023	Kestra Private Wealth Services LLC	16,732	$28K	0.0%	N/A	0.030%
8/7/2023	Acadian Asset Management LLC	162,467	$0.27M	0.0%	N/A	0.291%
8/4/2023	HBK Sorce Advisory LLC	42,348	$70K	0.0%	-50.0%	0.076%
8/2/2023	Bank of Montreal Can	19,230	$42K	0.0%	N/A	0.034%
5/11/2023	Financial Advocates Investment Management	25,000	$28K	0.0%	-21.9%	0.045%
4/18/2023	Vahanian & Associates Financial Planning Inc.	718,908	$0.82M	2.3%	+6.0%	1.287%
2/1/2023	Vahanian & Associates Financial Planning Inc.	678,258	$0.61M	2.0%	-2.4%	1.252%
11/3/2022	Vahanian & Associates Financial Planning Inc.	695,258	$0.81M	2.8%	+24.9%	1.303%
8/11/2022	Beacon Pointe Advisors LLC	60,000	$38K	0.0%	N/A	0.112%
8/10/2022	Mackenzie Financial Corp	61,699	$39K	0.0%	N/A	0.116%
8/5/2022	Cowen AND Company LLC	124,590	$80K	0.0%	N/A	0.281%
7/27/2022	Vahanian & Associates Financial Planning Inc.	556,758	$0.36M	1.5%	+7.0%	1.257%
5/11/2022	GSA Capital Partners LLP	34,769	$91K	0.0%	-64.4%	0.083%
4/27/2022	Vahanian & Associates Financial Planning Inc.	520,158	$1.36M	3.1%	-44.1%	1.254%
4/19/2022	Graypoint LLC	413,817	$1.08M	0.1%	N/A	0.998%
2/14/2022	PDT Partners LLC	91,611	$0.36M	0.0%	+20.4%	0.228%
2/14/2022	GSA Capital Partners LLP	97,802	$0.38M	0.0%	-67.1%	0.244%
2/10/2022	Connor Clark & Lunn Investment Management Ltd.	28,382	$0.11M	0.0%	N/A	0.071%
2/4/2022	IndexIQ Advisors LLC	81,213	$0.32M	0.0%	-6.1%	0.202%
1/28/2022	Vahanian & Associates Financial Planning Inc.	929,975	$3.62M	2.9%	N/A	2.315%
12/1/2021	Balyasny Asset Management LLC	148,061	$0.65M	0.0%	N/A	0.369%
11/15/2021	Balyasny Asset Management LLC	148,061	$0.65M	0.0%	N/A	0.369%
11/15/2021	GSA Capital Partners LLP	297,229	$1.30M	0.1%	+203.9%	0.740%
11/12/2021	Renaissance Technologies LLC	189,669	$0.83M	0.0%	-22.7%	0.472%
11/12/2021	Jump Financial LLC	49,700	$0.22M	0.0%	+62.3%	0.124%
11/10/2021	Goldman Sachs Group Inc.	73,165	$0.32M	0.0%	+7.5%	0.182%
11/10/2021	IndexIQ Advisors LLC	86,461	$0.38M	0.0%	+11.1%	0.215%
11/9/2021	Barclays PLC	27,926	$0.12M	0.0%	-11.0%	0.070%
11/9/2021	BlackRock Inc.	330,946	$1.44M	0.0%	-5.7%	0.824%
9/17/2021	Virtu Financial LLC	18,521	$74K	0.0%	N/A	0.048%
8/17/2021	Millennium Management LLC	437,854	$1.74M	0.0%	N/A	1.126%
8/17/2021	Bridgeway Capital Management LLC	127,000	$0.50M	0.0%	-16.4%	0.327%
8/17/2021	Caas Capital Management LP	217,091	$0.86M	0.0%	N/A	0.558%
8/16/2021	Squarepoint Ops LLC	19,824	$79K	0.0%	N/A	0.051%
8/16/2021	LMR Partners LLP	12,090	$48K	0.0%	N/A	0.031%
8/16/2021	PDT Partners LLC	81,765	$0.33M	0.0%	N/A	0.210%
8/16/2021	Alberta Investment Management Corp	150,000	$0.60M	0.0%	N/A	0.386%
8/16/2021	Charles Schwab Investment Management Inc.	74,757	$0.30M	0.0%	-56.7%	0.192%
8/16/2021	State Street Corp	69,877	$0.28M	0.0%	-78.4%	0.180%
8/16/2021	Tibra Equities Europe Ltd	78,100	$0.31M	0.1%	N/A	0.201%
8/16/2021	Goldman Sachs Group Inc.	68,030	$0.27M	0.0%	+45.3%	0.175%
8/13/2021	Renaissance Technologies LLC	245,448	$0.97M	0.0%	N/A	0.631%
8/13/2021	Northern Trust Corp	45,454	$0.18M	0.0%	-78.6%	0.117%
8/13/2021	Jump Financial LLC	30,630	$0.12M	0.0%	N/A	0.079%
8/13/2021	Brandywine Global Investment Management LLC	125,416	$0.50M	0.0%	-7.9%	0.323%
8/13/2021	Latash Investments LLC	243,134	$0.97M	0.6%	N/A	0.625%
8/13/2021	Geode Capital Management LLC	219,642	$0.87M	0.0%	-38.1%	0.565%

Data available starting January 2016

Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. Its proprietary product candidates comprise Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; KYNMOBI, a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease; and Exservan, an oral soluble film formulation of riluzole for the treatment of amyotrophic lateral sclerosis. The company's proprietary pipeline of complex molecule product includes AQST-108, a sublingual film formulation delivering systemic epinephrine for the treatment of conditions other than anaphylaxis; and Anaphylm, an epinephrine sublingual film for the emergency treatment of allergic reactions, including anaphylaxis. In addition, it develops Adrenaverse, an epinephrine prodrug platform. The company was incorporated in 2004 and is headquartered in Warren, New Jersey.

Today's Range

Now: $4.56

$4.39

$4.65

50 Day Range

MA: $4.99

$4.44

$5.66

52 Week Range

Now: $4.56

$1.84

$6.23

Volume

1,165,498 shs

Average Volume

1,682,472 shs

Market Capitalization

$415.78 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.82

Who are the company insiders with the largest holdings of Aquestive Therapeutics?: Aquestive Therapeutics' top insider shareholders include:
Alexander Mark Schobel (Insider)
Learn More about top insider investors at Aquestive Therapeutics.
Who are the major institutional investors of Aquestive Therapeutics?: Aquestive Therapeutics' top institutional investors include:
Geode Capital Management LLC — 1.83%
State Street Corp — 1.64%
Janney Montgomery Scott LLC — 1.01%
Charles Schwab Investment Management Inc. — 0.22%
Verition Fund Management LLC — 0.22%
Wellington Management Group LLP — 0.20%
Learn More about top institutional investors of Aquestive Therapeutics stock.
Which major investors are selling Aquestive Therapeutics stock?: In the last quarter, AQST stock was sold by these institutional investors:
Stifel Financial Corp
Virtu Financial LLC
PFG Investments LLC
Which major investors are buying Aquestive Therapeutics stock?: During the previous quarter, AQST stock was purchased by institutional investors including:
State Street Corp
Verition Fund Management LLC
Wellington Management Group LLP
GSA Capital Partners LLP
Chartwell Investment Partners LLC
Geode Capital Management LLC
Barclays PLC
Barclays PLC